Fosamax Lawsuit News

A study done by Columbia University investigated 111 women taking bisphosphonates including Fosamax.  Their studies demonstrated that early on in therapy patients showed marked improvement in bone structure but after long-term use bone structure diminished.  Further studies conducted at the Hospital for Special Surgery in New York observed 21 women who had femur fractures. Twelve of these patients who had been on bisphosphonates for over eight years demonstrated reduced bone mass as compared to the other 9 patients who did not take bisphosphonates.   Additionally, the Annals of Internal Medicine reported that bisphosphonates like Fosamax behave more like a bone hardener than a bone builder.  They have also observed that bone becomes brittle over time with the use of Fosamax.